The members of the WSLHD Board are appointed by the NSW Minister for Health for a term of up to four years.
Mr Richard Alcock AO (Chair)
BCom, LLB (UNSW)
Richard Alcock joined the Board of WSLHD in August 2016 after five years as deputy chairman and chairman of the Finance and Performance Committee of the Sydney Children’s Hospitals Network (SCHN).
Prior to his appointment to the SCHN board, he was a director of the Sydney Children’s Hospitals Foundation.
In 2017 he was appointed Vice Chairman of Bank of America Merrill Lynch.
He was previously the Managing Director and Co-Head of Transport, Infrastructure, Power & Utilities at Merrill Lynch Markets (Australia) Pty Limited from 2007.
Formerly a corporate lawyer for 25 years with Allens Arthur Robinson he worked in Sydney, Singapore and Jakarta, was made a senior partner, head of Governance, and chairman of the Ethics Committee.
Richard is a director of the UNSW Foundation Limited, and Art Exhibitions Australia Limited, a not-for-profit company limited by guarantee, established to bring major art exhibitions to Australia in partnership with State galleries and museums.
In 2017, Richard was awarded the Officer (AO) in the General Division, for distinguished service to the community, particularly through health management roles, and to the law, corporate governance, and higher education organisations.
Professor Jeremy Chapman AC (Deputy Chair)
MB, BChir, MD, FRACP, FRCP
Jeremy is the Clinical Director of the Division of Medicine and Cancer at Westmead Hospital and Director of the Western Renal Service.
His work in transplantation has been recognised nationally and internationally.
He is Chairman of the Australian Bone Marrow Donor Registry and the Australian Cord Blood Bank Network; a member of the Australian Organ and Tissue Authority’s Advisory Council; past-president of The Transplantation Society; advisory member of the World Health Organisation’s Expert Advisory Panel on Human Cell Tissue and Organ Transplantation; secretary general and past president of the World Marrow Donor Association, and the inaugural co-chair of the Declaration of Istanbul Custodian Group.
Jeremy has more than 400 peer-reviewed publications and is editor-in-chief of the Transplantation and Transplantation Direct journals.
Adjunct Professor Kathy Baker AM
M EdA, BHA, RN, CC, CT, Dip NE, MAICD, ACN (DLF), Honorary Fellow UTS, Wharton Fellow
A registered nurse, Kathy is an adjunct professor with the University of Technology, Sydney, the University of Sydney, and Western Sydney University.
Kathy is a non-executive director on the boards of the Australian College of Nursing, RSL Care + Royal District Nursing Service and chair of its Clinical Governance, Client Safety & Well Being Committee.
Kathy is the nurse advisor at the Australian Commission on Safety and Quality in Health Care and an advisor to Evercare Health Limited, Hong Kong.
Ms Narelle Bell
Narelle is Australia's Aircraft Noise Ombudsman.
She is also the legal member of WSLHD’s Human Research Ethics Committee, a member of the Centre for Health Record Linkage Community Advisory Committee, and the former legal member of the NSW Medical Council.
She has worked as a lawyer in the private, public and community sectors including as a founding volunteer at Macquarie Legal Centre in Parramatta, principal solicitor at Redfern Legal Centre and as assistant director of Legislation and Policy in the NSW Attorney General’s Department.
From 1994 Narelle was a member of the Social Security Appeals Tribunal, the Equal Opportunity Tribunal, the NSW Administrative Decisions Tribunal, and from 2001 she served 13 years as a senior member of the Commonwealth Administrative Appeals Tribunal.
Over the past decade she has taught reasoning, writing and hearing skills to courts, tribunals, agency decision makers and expert witnesses in Australia and overseas and continues as a consultant in these and other law and public administration related areas.
Mr Andrew Bernard
BSc (Syd), MPH (Syd), Grad Cert BA (Exec) (Monash Mt Eliza), AFCHSM, MAICD
Andrew has been a resident of western Sydney since 1977.
He has worked in the NSW public health system since 1975.
Senior appointments have included general manager at Bowral and District, Fairfield, and Bankstown-Lidcombe hospitals; general manager of Clinical Services at the former Sydney South West Area Health Service; and director of operations at the Prince of Wales and Sydney hospitals from 2007 until his retirement in April 2013.
Andrew’s experience as a non-executive director since 1996 has included terms on the boards of Service for the Treatment and Rehabilitation of Torture and Trauma Survivors (STARTTS), Bankstown City Aged Care, The Health-Science Alliance, Neuroscience Research Australia (NeuRA), Prince of Wales Hospital Foundation, and the Health Roundtable Limited.
Ms Elizabeth Crouch
BEc (MU), FAICD
Elizabeth is an experienced company director and business consultant.
She spent 16 years with the Federal government in health and disability services before moving into the private sector where she held various positions, including the role of Chief Executive of the Housing Industry Association.
Elizabeth is a highly respected executive coach and moderator for the Orijen Group and has mentored women in industry, health and higher education.
Elizabeth is the Deputy Chancellor of Macquarie University, a non-executive Director of McGrath Ltd, SGS Economics and Planning, and is a Trustee of the Museum of Applied Arts and Sciences.
Elizabeth chairs a number of audit committees including for the City of Sydney, Environment and Heritage and Railcorp and is a member of the Health Infrastructure and IPART audit committees.
Elizabeth is a Director of Optimize International, a strategic consultancy and advisory firm and continues to support a range of community and sporting bodies including as the air of the Women's university rugby 7s and Deputy Chair of the Sydney Rays rugby franchise.
Professor Michael Edye
Michael is the director, Division of Surgery and Anaesthetics at Blacktown and Mount Druitt hospitals.
A pioneer in laparoscopic surgery, Michael was recruited to The Mount Sinai Hospital in New York in 1993 where he practiced for 20 years establishing the new discipline.
He worked as a national advocate to the American Medical Association and US Medicare in the areas of surgical coding and reimbursement.
In 2013 he returned to Australia as Chair of Surgery at the Clinical School of Western Sydney University.
Professor Donald Nutbeam
PhD, FFPH (UK)
Don Nutbeam shares his time as a professor of Public Health at the University of Sydney, and a Senior Advisor at the Sax Institute, and with Sydney Health Partners.
Don returned to Sydney in 2016 following a six-year-term as Vice-Chancellor (President) of the University of Southampton, UK.
His career has spanned senior positions in universities, government, health services and an independent health research institute.
He served as the head of Public Health in the UK Department of Health, responsible for leading policy development on a range of complex and large-scale public health challenges.
Don has worked as an advisor on public health issues for the World Health Organisation for more than 30 years, and as consultant and team leader in health system capacity development projects for the World Bank.
Professor Diana O'Halloran AO
MBBS, MPHEd, FRACGP, FAICD
Di is a general practitioner with a longstanding involvement in primary healthcare reform and the development of new service and care models including HealthOne, Connecting Care and Integrated Care.
She chairs the Western Sydney Primary Health Network, WentWest Ltd, which works in partnership with the LHD to improve community needs assessment, planning, coordination and integration of care in the community and across the hospital-community interface.
A conjoint professor in the Department of General Practice, Western Sydney University, Di is the Chair of the NSW&ACT PHN Council and Co-Chair of the Agency for Clinical Innovation's General Practice Advisory Group. She is a board member of the NSW and ACT Faculty of the Royal Australian College of General Practitioners. Di chaired the NSW General Practice Council advising the Minister between 2004 and 2011, and nationally, was a member of the RACGP Council, General Practice Education and Training Board and the Australian Medicare Local Alliance Board.
Dr Andrew Pesce
Andrew is a leading obstetrician and gynaecologist at Westmead Hospital.
As federal president of the Australian Medical Association in 2009 he vigorously advocated for public hospitals and clinician engagement during the national health reforms.
Locally, he chaired the Westmead Medical Staff Council from 2008-2009.
His long association with Westmead Hospital began as an intern in 1984, eventually training in Obstetrics and Gynaecology and became Clinical Superintendent in 1990.
In 1993 Andrew was appointed to a staff specialist position and in 2004 he became a visiting medical officer, and was clinical director of Women’s and Children’s Health from 2007 to 2011. He currently is the consultant heading the Breech Clinic at Westmead.
Professor Christopher Liddle
BSc(Med), MB.BS, PhD, FRACP
Chris is an academic Hepatologist and Clinical Pharmacologist at Westmead Hospital and the Western Clinical School, University of Sydney. Chris is head of the Department of Clinical Pharmacology and Toxicology, Westmead Hospital. In addition to managing patients with liver disease, poisoning and overdose, Chris has key governance roles across the Western Sydney Local Health District (WSLHD), including chairing the Westmead Hospital Medical Staff Council and the WSLHD Drug and Therapeutics Committee.
Chris is a senior university representative for the Westmead Redevelopment, especially in the area of information technology. At a State level, Chris was the lead clinician for the eHealth NSW $170M electronic medication prescribing and management (eMeds) project and chairs the NSW Therapeutic Advisory Group.
Chris’ main area of research has been the functional genomics of liver metabolism and liver diseases, utilising recent technological developments in DNA sequencing and bioinformatics in order to elucidate new drug targets in areas of high therapeutic need. Much of this work has been performed in collaboration with the prestigious Salk Institute, San Diego, where Chris was appointed an adjunct professor in 2010. Chris’ research has led to many high impact publications as well as several patent families, two of which have been successfully commercialised.
Professor Mark McLean
B.Med, PhD, FRACP
Mark is a clinical endocrinologist and medical academic. He has been on the senior medical staff at Blacktown, Mount Druitt and Westmead Hospitals since 1996.
Mark has been involved in clinical teaching for more than 20 years, was Director of Physician Training at Westmead Hospital 2005-2009, and Foundation Professor of Medicine at the Blacktown Clinical School of Western Sydney University 2009-2016.
Mark's current role is Medical Director in the Division of Ambulatory Medicine at Blacktown and Mount Druitt hospitals, and Conjoint Professor of Medicine at WSU. He also chairs the Blacktown Mount Druitt Hospitals Medical Staff Council.
Mark is engaged in clinical and basic science research in the field of diabetes and endocrinology. He also works with a team of clinicians and researchers at Blacktown who are trying to optimize the health system for management and prevention of diabetes in western Sydney.
Mark is a Past-President of the Endocrine Society of Australia, and a member of the National Examining Panel of the Royal Australasian College of Physicians. He is passionate about the development of education and research as important roles of our public hospitals.
Mr Adam Stuart
Adam Stuart has extensive experience in the health sector. Over the last 15 years, Adam has worked in the Aboriginal community control health sector and in state and federal governments in Aboriginal health. His roles have centered on management, program development and project management. Adam has a passion for the Aboriginal Community Controlled Health sector and is strongly committed to improving the health and well-being of Aboriginal people.
Over the years, Adam has been a member of many state and national committees. Most recently, he has been a member of the NSW Better Cardiac Care Advisory Committee for Aboriginal people and the Aboriginal Advisory Committee. At the national level, he has assisted the Australian Commission on Safety and Quality in Health Care with a project to improve the care provided to Aboriginal and Torres Strait Islander people in health service organisations, using the National Safety and Quality Health Service Standards as a framework.
Adam is an Arabana man. His people originate from the far north of South Australia and are the traditional owners of the Kati Thanda-Lake Eyre region.
The following ex-officio Board members participate in agenda items relating to their areas of expertise:
Mr Graeme Loy
WSLHD Chief Executive
Over the last 12 years Graeme has held a number of executive roles, including Chief Executive for NSLHD. His knowledge of both clinical and corporate services includes a strong focus on system performance through healthy relationships.
Graeme has accumulated significant experience in all aspects of leadership in both the public and private sectors. He takes great pride being able to deliver highly complex clinical services through high performing teams.
His breadth of knowledge spans facility, district and statewide environments and enables him to couple strategic direction with the broader improvement and research goals, including ensuring optimal provision of safe, high quality and timely clinical services in concert with the needs of the community and the health system.
With patients as his principle focus Graeme strives to support NSW Health to deliver high quality care and brings a simple motto to each discussion – “What if it was your mum?”
Adjunct Associate Professor Robynne Cooke
Executive Director Operations
RN, BN, Grad Dip Gerontology, MHSM, GAICD
Robynne commenced with WSLHD in January 2018 and is broadly accountable for the operations of WSLHD.
Previously the General Manager of Liverpool Hospital from 2014-2017, Robynne has a distinguished 20-year record of service in healthcare dealing with corporate and clinical sectors.
Her experience has equipped her with an extensive understanding of the healthcare challenges in Sydney’s west, and executive level health service management.
She has a deep commitment to innovation. Under her stewardship, the robotic surgery program was implemented and the Australian Pacific Minimal Invasive and Robotic Surgery Training Centre developed at Liverpool Hospital.
B Comm (Econ), Dip. Acc, MBA, CPA
Appointed in July 2018, Barry brings strong governance and rigour to WSLHD’s financial, strategy and operational management. Barry’s tertiary education was completed at the University of Wollongong and he holds a Master in Business Administration. He is also a qualified CPA.
Barry has more than 35 years’ experience in finance oversight including 30 years with NSW Health, predominantly with Illawarra Shoalhaven LHD. He has worked with all levels of NSW Health and understanding the ‘needs of the business’ is the basis of his strategic and operational approach.
Barry is driven to ensure WSLHD is financially sustainable to deliver the best available healthcare to the people of western Sydney.